Clin2
NCT07206472Possibly a fitRecruiting

Study of bempedoic acid for high cholesterol

Primary HypercholesterolaemiaMixed Dyslipidemia

Part of Heart & circulation clinical trials.

This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,120 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have high cholesterol or a mixed lipid disorder.
  • Your doctor has prescribed or plans to prescribe bempedoic acid or the combination pill.
  • If you already take this medicine, you started within the last 3 months.
  • You do not have any conditions that make this medicine unsafe for you.
  • You are not taking part in another clinical trial that tests a treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07614958Recruiting· Phase 3
Testing a new cholesterol medicine against bempedoic acid

This study compares two new medicines—obicetrapib and bempedoic acid—to see which one better lowers cholesterol in people whose cholesterol remains high despite taking standard medications. If your cholesterol isn't controlled well enough with current drugs, this trial may help you access an experimental treatment.

Stockton-on-Tees
NCT07474649Not yet recruiting· Phase 3
Triple cholesterol medicine for heart disease prevention

This trial tests a triple combination of medications (bempedoic acid, ezetimibe, and a high-intensity statin) in people who have never had a heart attack or stroke but have moderate to severe coronary artery disease. The goal is to see if this combination lowers cholesterol and reduces future heart risks more effectively than standard care.

Berlin
NCT06314919Recruiting
Study of a combination pill for high cholesterol

This study tests a single pill that combines two cholesterol-lowering medicines (pitavastatin and ezetimibe). It may be a good fit if you already take a statin or a statin plus ezetimibe and your doctor wants to adjust your treatment.

Seoul
NCT06646354Enrolling by invitation· Phase 3
Study of two experimental drugs for high blood pressure and cholesterol

This trial tests whether taking two experimental drugs together can safely lower both high blood pressure and high cholesterol. It may be an option if you have both conditions and your blood pressure is not extremely high.

Seoul
NCT06780410Recruiting· Phase 3
Study of bempedoic acid for lowering cholesterol

This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.

Beijing
NCT07623915Not yet recruiting· Phase 3
Bempedoic acid for lowering cholesterol in high-risk patients

This study tests a new medicine called bempedoic acid that helps lower LDL (bad) cholesterol in people who are already on statins or other cholesterol treatments. It may offer an additional option for people who need to lower their cholesterol further because of heart disease risks.

Hear when a new Mixed Dyslipidemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.